Text Size

Sinusitis in Children and the Nasopharyngeal Microbiome

This study is currently recruiting participants.
Verified February 2012 by University of Wisconsin, Madison
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT01492868
First received: December 13, 2011
Last updated: February 14, 2012
Last verified: February 2012
History of Changes
  Purpose

The purpose of this study is to investigate the relationship between viral infections of the upper respiratory tract, perturbations of the nasopharyngeal microbiome in children, and the risk of acute bacterial sinusitis over a one year period. The investigators will determine the incidence of acute bacterial sinusitis post viral upper respiratory infection and identify the viral antecedent infections and other risk factors which predispose to infection and ultimately design strategies to reduce the burden of disease and antimicrobial resistance.


Condition
Sinusitis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sinusitis in Children and the Nasopharyngeal Microbiome

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Wisconsin, Madison:

Biospecimen Retention:   Samples Without DNA

Nasopharyngeal microbiome samples


Estimated Enrollment: 355
Study Start Date: January 2012
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   4 Years to 7 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Healthy children

Criteria

Inclusion Criteria:

  • Children 4 to 7 years of age
  • Healthy
  • English-speaking parent/guardian -

Exclusion Criteria:

  • Any underlying condition which would predispose them to the development of sinusitis including congenital or acquired immunodeficiencies
  • Craniofacial abnormalities
  • Cystic fibrosis
  • Allergic rhinitis or a previous episode of chronic sinusitis.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01492868

Contacts
Contact: Stacey Moyer, MSN (608) 262-9531 scmoyer@pediatrics.wisc.edu

Locations
United States, Wisconsin
UW Health West Towne Pediatrics Recruiting
Madison, Wisconsin, United States, 53717
Contact: Stacey Moyer, MSN     608-262-9531     scmoyer@wisc.edu    
UW Pediatrics at 20 S. Park St Recruiting
Madison, Wisconsin, United States
Contact: Stacey Moyer, MSN     608-262-9531     scmoyer@wisc.edu    
Sponsors and Collaborators
University of Wisconsin, Madison
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Investigators
Principal Investigator: Ellen R Wald, MD University of Wisconsin, Madison
  More Information

Additional Information:
University of Wisconsin-Madison Department of Pediatrics Research Information  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT01492868     History of Changes
Other Study ID Numbers: GRANT 10785179, 1R01AI097172-01
Study First Received: December 13, 2011
Last Updated: February 14, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Wisconsin, Madison:
sinusitis
upper respiratory infection

Additional relevant MeSH terms:
Sinusitis
Paranasal Sinus Diseases
Nose Diseases
 Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on May 16, 2013